Clinical value of serum AFP and PIVKA‐II for diagnosis, treatment and prognosis of hepatocellular carcinoma

BACKGROUND: The accuracy of alpha‐fetoprotein (AFP) as a diagnostic marker for hepatocellular carcinoma (HCC) is insufficient, and the application of abnormal prothrombin (PIVKA‐II) in HCC is still controversial. METHODS: Serum AFP and PIVKA‐II levels were analyzed in 145 cases of HCC, 57 of benign...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Shan, Chen, Yongyi, Zhang, Yimin, Xu, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833986/
https://www.ncbi.nlm.nih.gov/pubmed/36579611
http://dx.doi.org/10.1002/jcla.24823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833986/
https://www.ncbi.nlm.nih.gov/pubmed/36579611
http://dx.doi.org/10.1002/jcla.24823

Ejemplares similares